Cartesian Therapeutics: Peers

The FY2025 (Dec) proxy of Cartesian Therapeutics names 19 peer companies for pay. Among Cartesian Therapeutics and these peers, CEO pay was 6th highest of 12 and total shareholder return was 10th highest of 12.

6th highest of 12in Cartesian Therapeutics and its pay peers, FY2025 (Dec) by CEO pay:

$2.1M$27.8M

10th highest of 12in Cartesian Therapeutics and its pay peers, FY2025 (Dec) by total shareholder return:

$18$906

Pay peer group, FY2025 (Dec) proxy

Cogent Biosciences
MeiraGTx Holdings
Corvus Pharmaceuticals
Anaptysbio
Savara
Regenxbio
Replimune Group
Annexon
Rocket Pharmaceuticals
Lineage Cell Therapeutics
4D Molecular Therapeutics
AlectorNot disclosedNot disclosed
Allogene TherapeuticsNot disclosedNot disclosed
Cabaletta BioNot disclosedNot disclosed
Candel TherapeuticsNot disclosedNot disclosed
MacrogenicsNot disclosedNot disclosed
RezoluteNot disclosedNot disclosed
Viridian TherapeuticsNot disclosedNot disclosed
Vor BiopharmaNot disclosedNot disclosed
19 companies

Changes by year

No proxy on file names a change to the peer group.

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.